Skip to content

Opening book details…

About this Medicine article

Inhibition of ACK1 delays and overcomes acquired resistance of EGFR mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib by Gu, Jiajia; Qian, Luxi; Zhang, Guojing; Mahajan, Nupam P.; Owonikoko, Taofeek K.; Ramalingam, Suresh S.; Sun, Shi-Yong is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Gu, Jiajia; Qian, Luxi; Zhang, Guojing; Mahajan, Nupam P.; Owonikoko, Taofeek K.; Ramalingam, Suresh S.; Sun, Shi-Yong
Publisher
Elsevier Science; Elsevier ; Elsevier BV (ISSN 0169-5002)
Published
2020
Field
Medicine (Health Sciences)

More by Gu, Jiajia; Qian, Luxi; Zhang, Guojing; Mahajan, Nupam P.; Owonikoko, Taofeek K.; Ramalingam, Suresh S.; Sun, Shi-Yong

Browse all works by Gu, Jiajia; Qian, Luxi; Zhang, Guojing; Mahajan, Nupam P.; Owonikoko, Taofeek K.; Ramalingam, Suresh S.; Sun, Shi-Yong